HANNAH BARROWS: Open Payments
NPI 1528747128 · SANTA MARIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 28 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $152 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $346 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
| Ardelyx, Inc. | 1 | $34 |
| Aimmune Therapeutics, Inc. | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Ipsen Biopharmaceuticals, Inc | 1 | $27 |
| Boston Scientific Corporation | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $18 |
Products named: RINVOQ, XIFAXAN, SKYRIZI, CREON, IBSRELA, ZENPEP, ENTYVIO, IQIRVO.
Industry payments across CA — which companies pay providers there.
